The arrival of safe, effective COVID-19 vaccines is a major development in the coronavirus pandemic. An effective COVID-19 vaccine will help protect people who come in contact with the virus from becoming sick. As more people are vaccinated, families and communities will be able to gradually return to a more normal routine.
Yes, research to date indicates the vaccines for COVID-19 have a very good safety profile. The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for two COVID-19 vaccines. Both have been tested in large clinical trials. Data from the manufactures show that the known and potential harms of becoming infected with the coronavirus disease 2019 (COVID 19) outweigh the potential safety risks of the vaccines.
Even though the coronavirus vaccines were developed more quickly than other vaccines in the past, they have been carefully tested and continue to be monitored. The U.S. vaccine safety system works to make sure that all vaccines are as safe as possible. Safety has been a top priority as federal agencies work with vaccine manufacturers to develop and authorize a COVID-19 vaccine. Here are some key areas of COVID-19 vaccine development, review and authorization.
Some side effects include:
Common side effects of the COVID-19 vaccination include fever, chills, fatigue and body aches; these symptoms usually last 1-2 days and taking Paracetamol can reduce the severity of these symptoms in most cases.